Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

GERMANY/ITALY: OXON ITALIA TAKES OVER DEGUSSA ARM

Article Abstract:

In order to meet the conditions set by the European Union for the VIAG/Veba/E.On merger, Degussa AG of Germany has divested the sales and marketing of cyanuric chloride and sodium dicyanamide to Oxon Italia S.p.A. The Italian company is a producer of fine chemicals, agrochemical intermediaries and active agents with an annual turnover of more than EUR 130mn.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
Italy, Industrial Chemicals, Basic Chemical Manufacturing, CHEMICALS AND ALLIED PRODUCTS, Degussa AG, Oxon Italia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GERMANY: INTERACTIVA BIOTECHNOLOGIE TO HYBAID

Article Abstract:

Hybaid, a German subsidiary of Thermo Bio-Analysis Corp of Santa Fe, is complementing its range of thermocyclers and reagents for DNA amplification by taking over the German Ulm-based company Interactiva Biotechnologie GmbH, a company involved in biomolecule synthesis for research.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
Acquisitions & mergers, Chemicals & Allied Products, Chemical Manufacturing, Chemicals, Hybaid, Interactiva BioTechnologie GmbH

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Germany
Similar abstracts:
  • Abstracts: GERMANY: STAGNATION IN COATINGS INDUSTRY. ITALY: ALTANA TAKES OVER SIDERIUS ARM
  • Abstracts: GERMANY: BIOCARE BOUGHT BY MODEX. GERMANY: DELTON FLEXIBLE PACKAGING TO PENTAPLAST. GERMANY: HYDRO CHEMICALS UNITS TO KRUSE CHEMIE
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.